Test Bank:
+y
Advanced Pharmacology for Prescribers 1st Edition Luu Kayingo Latest
+y +y +y +y +y +y +y +y
Edition, 2024
+y +y
, Table of Contents +y +y
Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines ........................................ 3
+y +y +y +y +y +y +y +y
Chapter 2: Pharmacokinetics /Chapter3: Pharmacodynamics .................................................................. 13
+y +y +y +y
Chapter4: Pharmacogenetics and Pharmacogenomics .............................................................................. 25
+y +y +y
Chapter 5: Pharmacology Across the Life Span...................................................................................... 30
+y +y +y +y +y +y
Chapter 6: Drug-Therapy Prescribing in Special Populations ................................................................ 36
+y +y +y +y +y +y
Chapter 7: Drug Development and Approval .......................................................................................... 45
+y +y +y +y +y
Chapter 8-Chapter 10: Foundations of Prescription Writing Chapter 9: ResponsibleControlled-
+y +y +y +y +y +y +y +y +y
Substance Prescribing Chapter 10: Antibiotic Stewardship ...................................................................... 51
+y +y +y +y +y
Chapter 11: Applied Calculations for Prescribing ................................................................................... 58
+y +y +y +y +y
Chapter 12-: Promoting Adherence With Pharmacotherapy II: System-Specific and Patient-
+y +y +y +y +y +y +y +y +y
Focused Prescribing Chapter 13: Pharmacotherapy for Ear, Nose, Mouth, andThroat Conditions /Chap
+y +y +y +y +y +y +y +y +y +y +y
ter 14: Pharmacotherapy for Eye Conditions ............................................................................................ 67
+y +y +y +y +y
Chapter 15: Pharmacotherapy for Skin Conditions ................................................................................. 74
+y +y +y +y +y
Chapter 16: Pharmacotherapy for Neurologic Conditions ...................................................................... 81
+y +y +y +y +y
Chapter 17: Pharmacotherapy for Cardiovascular Conditions................................................................ 94
+y +y +y +y +y
Chapter 18: Pharmacotherapy for Respiratory Conditions ................................................................... 106
+y +y +y +y +y
Chapter 19: Pharmacotherapy for Gastrointestinal Conditions and Conditions RequiringNutritional Sup
+y +y +y +y +y +y +y +y +y
port............................................................................................................................................................. 117
Chapter 20: Pharmacotherapy for Genitourinary Conditions ................................................................ 128
+y +y +y +y +y
Chapter 21: Pharmacotherapy for Renal, Acid–Base, Fluid, and Electrolyte Disorders .................... 133
+y +y +y +y +y +y +y +y +y
Chapter 22: Pharmacotherapy for Musculoskeletal and Rheumatologic Conditions .......................... 146
+y +y +y +y +y +y +y
Chapter 23: Therapeutic Applications of Immunology and Vaccines ................................................ 158
+y +y +y +y +y +y +y
Chapter 24: Pharmacotherapy for Endocrine Disorders ........................................................................ 163
+y +y +y +y +y
Chapter 25: Pharmacotherapy for Hematologic Disorders .................................................................... 174
+y +y +y +y +y
Chapter 26: Hematology/Oncology and Supportive Care for the Nononcologist ............................... 190
+y +y +y +y +y +y +y +y
Chapter 27: Pharmacotherapy Related to Women’s Health Conditions ............................................. 196
+y +y +y +y +y +y +y
Chapter 28: Pharmacotherapy Related to Men’s Health Conditions ................................................... 211
+y +y +y +y +y +y +y
Chapter 29: Pharmacotherapy Related to Transgender Care................................................................ 217
+y +y +y +y +y +y
Chapter 30: Antimicrobial Pharmacotherapy .......................................................................................... 224
+y +y +y
Chapter 31: Antiretroviral Pharmacotherapy .......................................................................................... 235
+y +y +y
Chapter 32: Psychopharmacology and Integrative Health: Combined Treatment ofPsychiatric and Neu
+y +y +y +y +y +y +y +y +y +y
rocognitive Conditions .............................................................................................................................. 247
+y
Chapter 33: Pharmacotherapy for Pain Management ............................................................................ 257
+y +y +y +y +y
Chapter 34: Substance Use Disorder III: Health Promotion and Maintenance ................................... 267
+y +y +y +y +y +y +y +y +y
Chapter 35: Over-the-Counter Medications ............................................................................................ 283
+y +y +y
Chapter 36: Pharmacotherapy for Obesity ............................................................................................. 291
+y +y +y +y
,Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines
+y +y +y +y +y +y +y +y
MULTIPLE CHOICE +y
• What is the primary purpose of the nursing assessment?
+y +y +y +y +y +y +y +y
A. Identifying underlying pathologic conditions +y +y +y
B. Assisting the physician in identifying medical conditions
+y +y +y +y +y +y
C. Determining the patients mental status +y +y +y +y
D. Exploring patient responses to health problems +y +y +y +y +y
ANS: D +y
A nursing assessment is done to identify the patients response to health
+y +y +y +y +y +y +y +y +y +y +y +
yproblems. During the nursing assessment phase, a comprehensive infor
+y +y +y +y +y +y +y +y
mation base is developed through a physical examination, nursing histor
+y +y +y +y +y +y +y +y +y
y, medication history, and professional observation. Identifying underlyi
+y +y +y +y +y +y +y
ng pathologic conditions and assisting the physician in identifying medi
+y +y +y +y +y +y +y +y +y
cal conditions is not part of the nursing process. Determining the patien
+y +y +y +y +y +y +y +y +y +y +y
ts mental status is one part of the nursing assessment, but it is not
+y +y +y +y +y +y +y +y +y +y +y +y +y +
ythe primary purpose.
+y +y
DIF: Cognitive Level: Comprehensio
+y +y +y
n REF: dm 36 OBJ: 1 | 3 TOP: Nurs
+y +y +y +y +y +y +y +y +y
ing Process Step: Assessment
+y +y +y
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
+y +y +y +y +y +y +y +y
• What is the basis of the NANDA I taxonomy?
+y +y +y +y +y +y +y + y
A. Functional health patterns +y +y
B. Human response patterns +y +y
C. Basic human needs +y +y
D. Pathophysiologic needs +y
ANS: B +y
The NANDA I taxonomy identifies human response patterns. Fu
+ y + y + y + y + y + y + y +y
nctional components of health patterns are limited to activity, fluid vol
+y +y +y +y +y +y +y +y +y +y
ume, nutrition, self care, and sensory perception. Basic human needs c
+y +y +y +y +y +y +y +y +y +y
omprise less than merely health patterns. Pathophysiologic needs are
+y +y +y +y +y +y +y +y + y
not part of the scope of NANDA I.
+y +y +y +y +y +y +y
, DIF: Cognitive Level: Knowledge RE
+y +y +y +y
F: pp. 37-38 OBJ: 5 TOP:
+y +y +y +y +y
Nursing Process Step: Diagnosis +y +y +y
MSC: NCLEX Client Needs Category: Physiological Integrity
+y +y +y +y +y +y
• Which task is included in the assessment step of the nursing process?
+y +y +y +y +y +y +y +y +y +y +y
A. Establishing patient goals/outcomes +y +y
B. Implementing the nursing care plan (NCP) +y +y +y +y +y
C. Measuring goal/outcome achievement +y +y
D. Collecting and communicating data +y +y +y
ANS: D +y
Data are collected and communicated in the assessment phase of the nu
+y +y +y +y +y +y +y +y +y +y +y
rsing process. Establishing goals is the function of planning.
+y +y +y +y +y +y +y +y
Implementing the NCP is the function of implementation. Measuring ou
+y +y +y +y +y +y +y +y +y
tcome achievement is the function of evaluation.
+y +y +y +y +y +y
DIF: Cognitive Level: Comprehensio
+y +y +y
n REF: dm 36 OBJ: 2 | 3 TOP: Nurs
+y +y +y +y +y +y +y +y +y
ing Process Step: Assessment
+y +y +y
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
+y +y +y +y +y +y +y +y
• Which statement regarding nursing diagnoses is accurate?
+y +y +y +y +y +y
a. Nursing diagnoses remain the same for as long as the disease is present.
+y +y +y +y +y +y +y +y +y +y +y +y
b. Nursing diagnoses are written to identify disease states.
+y +y +y +y +y +y +y
c. Nursing diagnoses describe patient problems that nurses treat.
+y +y +y +y +y +y +y
d. Nursing diagnoses identify causes related to illness.
+y +y +y +y +y +y
ANS: C +y
Diagnostic statements identify problems a nurse is independently able t
+y +y +y +y +y +y +y +y +y
o treat within the scope of professional practice. Nursing diagnoses var
+y +y +y +y +y +y +y +y +y +y
y with the changing condition of the patient. The response patterns are
+y +y +y +y +y +y +y +y +y +y +y +
unique to the patient and are not disease specific. Nursing diagnoses d
y +y +y +y +y +y +y +y +y +y +y +y
escribe the patients human response pattern.
+y +y +y +y +y
DIF: Cognitive Level: Comprehension
+y +y +y
+y
Advanced Pharmacology for Prescribers 1st Edition Luu Kayingo Latest
+y +y +y +y +y +y +y +y
Edition, 2024
+y +y
, Table of Contents +y +y
Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines ........................................ 3
+y +y +y +y +y +y +y +y
Chapter 2: Pharmacokinetics /Chapter3: Pharmacodynamics .................................................................. 13
+y +y +y +y
Chapter4: Pharmacogenetics and Pharmacogenomics .............................................................................. 25
+y +y +y
Chapter 5: Pharmacology Across the Life Span...................................................................................... 30
+y +y +y +y +y +y
Chapter 6: Drug-Therapy Prescribing in Special Populations ................................................................ 36
+y +y +y +y +y +y
Chapter 7: Drug Development and Approval .......................................................................................... 45
+y +y +y +y +y
Chapter 8-Chapter 10: Foundations of Prescription Writing Chapter 9: ResponsibleControlled-
+y +y +y +y +y +y +y +y +y
Substance Prescribing Chapter 10: Antibiotic Stewardship ...................................................................... 51
+y +y +y +y +y
Chapter 11: Applied Calculations for Prescribing ................................................................................... 58
+y +y +y +y +y
Chapter 12-: Promoting Adherence With Pharmacotherapy II: System-Specific and Patient-
+y +y +y +y +y +y +y +y +y
Focused Prescribing Chapter 13: Pharmacotherapy for Ear, Nose, Mouth, andThroat Conditions /Chap
+y +y +y +y +y +y +y +y +y +y +y
ter 14: Pharmacotherapy for Eye Conditions ............................................................................................ 67
+y +y +y +y +y
Chapter 15: Pharmacotherapy for Skin Conditions ................................................................................. 74
+y +y +y +y +y
Chapter 16: Pharmacotherapy for Neurologic Conditions ...................................................................... 81
+y +y +y +y +y
Chapter 17: Pharmacotherapy for Cardiovascular Conditions................................................................ 94
+y +y +y +y +y
Chapter 18: Pharmacotherapy for Respiratory Conditions ................................................................... 106
+y +y +y +y +y
Chapter 19: Pharmacotherapy for Gastrointestinal Conditions and Conditions RequiringNutritional Sup
+y +y +y +y +y +y +y +y +y
port............................................................................................................................................................. 117
Chapter 20: Pharmacotherapy for Genitourinary Conditions ................................................................ 128
+y +y +y +y +y
Chapter 21: Pharmacotherapy for Renal, Acid–Base, Fluid, and Electrolyte Disorders .................... 133
+y +y +y +y +y +y +y +y +y
Chapter 22: Pharmacotherapy for Musculoskeletal and Rheumatologic Conditions .......................... 146
+y +y +y +y +y +y +y
Chapter 23: Therapeutic Applications of Immunology and Vaccines ................................................ 158
+y +y +y +y +y +y +y
Chapter 24: Pharmacotherapy for Endocrine Disorders ........................................................................ 163
+y +y +y +y +y
Chapter 25: Pharmacotherapy for Hematologic Disorders .................................................................... 174
+y +y +y +y +y
Chapter 26: Hematology/Oncology and Supportive Care for the Nononcologist ............................... 190
+y +y +y +y +y +y +y +y
Chapter 27: Pharmacotherapy Related to Women’s Health Conditions ............................................. 196
+y +y +y +y +y +y +y
Chapter 28: Pharmacotherapy Related to Men’s Health Conditions ................................................... 211
+y +y +y +y +y +y +y
Chapter 29: Pharmacotherapy Related to Transgender Care................................................................ 217
+y +y +y +y +y +y
Chapter 30: Antimicrobial Pharmacotherapy .......................................................................................... 224
+y +y +y
Chapter 31: Antiretroviral Pharmacotherapy .......................................................................................... 235
+y +y +y
Chapter 32: Psychopharmacology and Integrative Health: Combined Treatment ofPsychiatric and Neu
+y +y +y +y +y +y +y +y +y +y
rocognitive Conditions .............................................................................................................................. 247
+y
Chapter 33: Pharmacotherapy for Pain Management ............................................................................ 257
+y +y +y +y +y
Chapter 34: Substance Use Disorder III: Health Promotion and Maintenance ................................... 267
+y +y +y +y +y +y +y +y +y
Chapter 35: Over-the-Counter Medications ............................................................................................ 283
+y +y +y
Chapter 36: Pharmacotherapy for Obesity ............................................................................................. 291
+y +y +y +y
,Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines
+y +y +y +y +y +y +y +y
MULTIPLE CHOICE +y
• What is the primary purpose of the nursing assessment?
+y +y +y +y +y +y +y +y
A. Identifying underlying pathologic conditions +y +y +y
B. Assisting the physician in identifying medical conditions
+y +y +y +y +y +y
C. Determining the patients mental status +y +y +y +y
D. Exploring patient responses to health problems +y +y +y +y +y
ANS: D +y
A nursing assessment is done to identify the patients response to health
+y +y +y +y +y +y +y +y +y +y +y +
yproblems. During the nursing assessment phase, a comprehensive infor
+y +y +y +y +y +y +y +y
mation base is developed through a physical examination, nursing histor
+y +y +y +y +y +y +y +y +y
y, medication history, and professional observation. Identifying underlyi
+y +y +y +y +y +y +y
ng pathologic conditions and assisting the physician in identifying medi
+y +y +y +y +y +y +y +y +y
cal conditions is not part of the nursing process. Determining the patien
+y +y +y +y +y +y +y +y +y +y +y
ts mental status is one part of the nursing assessment, but it is not
+y +y +y +y +y +y +y +y +y +y +y +y +y +
ythe primary purpose.
+y +y
DIF: Cognitive Level: Comprehensio
+y +y +y
n REF: dm 36 OBJ: 1 | 3 TOP: Nurs
+y +y +y +y +y +y +y +y +y
ing Process Step: Assessment
+y +y +y
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
+y +y +y +y +y +y +y +y
• What is the basis of the NANDA I taxonomy?
+y +y +y +y +y +y +y + y
A. Functional health patterns +y +y
B. Human response patterns +y +y
C. Basic human needs +y +y
D. Pathophysiologic needs +y
ANS: B +y
The NANDA I taxonomy identifies human response patterns. Fu
+ y + y + y + y + y + y + y +y
nctional components of health patterns are limited to activity, fluid vol
+y +y +y +y +y +y +y +y +y +y
ume, nutrition, self care, and sensory perception. Basic human needs c
+y +y +y +y +y +y +y +y +y +y
omprise less than merely health patterns. Pathophysiologic needs are
+y +y +y +y +y +y +y +y + y
not part of the scope of NANDA I.
+y +y +y +y +y +y +y
, DIF: Cognitive Level: Knowledge RE
+y +y +y +y
F: pp. 37-38 OBJ: 5 TOP:
+y +y +y +y +y
Nursing Process Step: Diagnosis +y +y +y
MSC: NCLEX Client Needs Category: Physiological Integrity
+y +y +y +y +y +y
• Which task is included in the assessment step of the nursing process?
+y +y +y +y +y +y +y +y +y +y +y
A. Establishing patient goals/outcomes +y +y
B. Implementing the nursing care plan (NCP) +y +y +y +y +y
C. Measuring goal/outcome achievement +y +y
D. Collecting and communicating data +y +y +y
ANS: D +y
Data are collected and communicated in the assessment phase of the nu
+y +y +y +y +y +y +y +y +y +y +y
rsing process. Establishing goals is the function of planning.
+y +y +y +y +y +y +y +y
Implementing the NCP is the function of implementation. Measuring ou
+y +y +y +y +y +y +y +y +y
tcome achievement is the function of evaluation.
+y +y +y +y +y +y
DIF: Cognitive Level: Comprehensio
+y +y +y
n REF: dm 36 OBJ: 2 | 3 TOP: Nurs
+y +y +y +y +y +y +y +y +y
ing Process Step: Assessment
+y +y +y
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
+y +y +y +y +y +y +y +y
• Which statement regarding nursing diagnoses is accurate?
+y +y +y +y +y +y
a. Nursing diagnoses remain the same for as long as the disease is present.
+y +y +y +y +y +y +y +y +y +y +y +y
b. Nursing diagnoses are written to identify disease states.
+y +y +y +y +y +y +y
c. Nursing diagnoses describe patient problems that nurses treat.
+y +y +y +y +y +y +y
d. Nursing diagnoses identify causes related to illness.
+y +y +y +y +y +y
ANS: C +y
Diagnostic statements identify problems a nurse is independently able t
+y +y +y +y +y +y +y +y +y
o treat within the scope of professional practice. Nursing diagnoses var
+y +y +y +y +y +y +y +y +y +y
y with the changing condition of the patient. The response patterns are
+y +y +y +y +y +y +y +y +y +y +y +
unique to the patient and are not disease specific. Nursing diagnoses d
y +y +y +y +y +y +y +y +y +y +y +y
escribe the patients human response pattern.
+y +y +y +y +y
DIF: Cognitive Level: Comprehension
+y +y +y
